查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）
市场调查报告书
商品编码
1463655

南美洲和中美洲脑脊髓液管理市场预测至 2030 年 - 区域分析 - 按产品（脑脊髓液分流器和脑脊髓液引流系统）和最终用户（医院、诊所、门诊手术中心等）

South & Central America Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 103 Pages | 订单完成后即时交付

价格

2022年，中南美洲脑脊髓液管理市场价值为9,252万美元，预计2030年将达到1.2,389亿美元；预计 2022 年至 2030 年CAGR为 3.7%。

神经系统疾病治疗中对脑脊髓液管理的日益关注推动了南美洲和中美洲脑脊髓液管理市场的发展

脑脊髓液参数作为成年患者神经系统疾病的生物标记被广泛评估。脑脊髓液中循环的 microRNA 是一类有前景的生物标记物，可用于诊断各种神经系统疾病。帕金森氏症 (PD)、阿兹海默症 (AD)、癫痫和癫痫等神经系统疾病通常会导致脑脊髓液参数改变。根据《自然》杂誌发表的一篇文章，与正常人相比，被诊断为 PD 的患者中发现 76 种脑脊髓液蛋白在结构上发生了变化。该研究还表明，这些脑脊髓液蛋白可用作诊断或治疗该疾病的生物标记。 PD 是一种与认知障碍和运动功能丧失相关的神经退化性疾病。根据世界卫生组织 (WHO) 2022 年发布的报告，帕金森氏症的盛行率在过去 25 年中翻了一番，影响了全球约 1% 的 60 岁以上人口。同样，患有癫痫发作或癫痫持续状态的患者的一些脑脊髓液参数（例如蛋白质和乳酸水平）也会发生变化。因此，利用脑脊髓液参数治疗癫痫发作或癫痫的各种研发活动正在进行中。此外，儘管市场上有各种使用CSF检测阿兹海默症的CSF测定法，但对用于检测和治疗目的的生物标记的需求尚未得到满足。随着阿兹海默症和帕金森氏症病例的增加，对脑脊髓液管理设备的需求也随之增加，因为脑脊髓液漏的病例可能会增加。因此，神经系统疾病盛行率的上升正在推动使用脑脊髓液管理产品治疗这些疾病的研发活动。

南美洲和中美洲脑脊髓液管理市场概述

南美洲和中美洲的脑脊髓液管理市场分为巴西、阿根廷以及南美洲和中美洲的其他地区。由于医疗设备进口的增加、需要先进医疗技术的医疗保健系统的不断发展以及老年人口的不断增长，预计该地区的市场将出现成长。

南美洲及中美洲脑脊髓液管理市场收入及 2030 年预测（百万美元）

南美洲和中美洲脑脊髓液管理市场细分

南美洲和中美洲脑脊髓液管理市场分为产品、最终用户和国家。

根据产品，南美洲和中美洲脑脊髓液管理市场分为脑脊髓液分流器和脑脊髓液引流系统。 2022 年，CCS 分流器细分市场将占据更大的市场。

根据最终用户，南美洲和中美洲脑脊髓液管理市场分为医院、诊所、门诊手术中心等。 2022 年，医院细分市场占据最大市场份额。

根据国家/地区，南美洲和中美洲脑脊髓液管理市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲脑脊髓液管理市场份额中占据主导地位。

B. Braun SE、Integra LifeSciences Holdings Corp、Medtronic Plc 和 Spiegelberg GmbH & Co KG 是南美洲和中美洲脑脊髓液管理市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲脑脊髓液管理市场模式

  • 概述
  • 南美洲和中美洲 PEST 分析

第 5 章：南美洲和中美洲脑脊髓液管理市场 - 主要产业动态

  • 市场驱动因素
    • 脑脊髓液漏病例增加
    • 政府为应对与 CSF 相关的日益增长的挑战而采取的倡议
  • 市场限制
    • 故障和故障的风险
  • 市场机会
    • 在神经系统疾病治疗中越来越关注脑脊髓液管理
  • 未来的趋势
    • 智慧型脑脊髓液分流器的开发
  • 影响分析：

第 6 章：脑脊髓液管理市场 - 南美洲和中美洲市场分析

  • 南美洲和中美洲脑脊髓液管理市场收入，2022 - 2030

第 7 章：南美洲和中美洲脑脊髓液管理市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年和 2030 年南美洲和中美洲脑脊髓液管理市场收入份额（按产品）
  • 脑脊髓液分流术
  • 脑脊髓液引流系统

第 8 章：南美洲和中美洲脑脊髓液管理市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年南美洲和中美洲脑脊髓液管理市场收入份额（按最终用户划分）（%）
  • 医院
  • 诊所
  • 门诊手术中心
  • 其他的

第 9 章：南美洲和中美洲脑脊髓液管理市场 - 国家分析

  • 概述
      • 南美洲和中美洲脑脊髓液管理市场（按国家/地区）
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 10 章：产业格局

  • 概述
  • 2020-2023 年南美洲和中美洲脑脊髓液管理市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Spiegelberg GmbH & Co KG

第 12 章：附录

Product Code: TIPRE00027992

The South & Central America cerebrospinal fluid management market was valued at US$ 92.52 million in 2022 and is expected to reach US$ 123.89 million by 2030; it is estimated to grow at a CAGR of 3.7% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the South & Central America Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

South & Central America Cerebrospinal Fluid Management Market Overview

The cerebrospinal fluid management market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The growth of the market in the region is expected due to several opportunities offered by increasing import of medical devices, growing developments of healthcare systems that demand advanced medical technologies and growing geriatric population.

South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

South & Central America Cerebrospinal Fluid Management Market Segmentation

The South & Central America cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the South & Central America cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the South & Central America cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America cerebrospinal fluid management market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the South & Central America cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 South & Central America PEST Analysis

5. South & Central America Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - South & Central America Market Analysis

  • 6.1 South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 South & Central America Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 Brazil
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 Brazil: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 Brazil: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 Brazil: South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Argentina
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Argentina: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Argentina: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Argentina: South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 Rest of South & Central America
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Spiegelberg GmbH & Co KG
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Cerebrospinal Fluid Management Market Segmentation
  • Table 2. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Recent Inorganic Growth Strategies in the South & Central America Cerebrospinal Fluid Management Market
  • Table 15. Recent Organic Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market
  • Table 16. Glossary of Terms, South & Central America Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. South & Central America Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: South & Central America Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. South & Central America Cerebrospinal Fluid Management Market, by Key Country-Revenue (2022) ($Mn)
  • Figure 22. South & Central America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. Brazil: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Argentina: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Rest of South & Central America: South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Growth Strategies in The South & Central America Cerebrospinal Fluid Management Market, 2020-2023